KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Adaptive Biotechnologies (ADPT) over the last 6 years, with Sep 2025 value amounting to -0.19%.

  • Adaptive Biotechnologies' Return on Capital Employed rose 22.00% to -0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.19%, marking a year-over-year increase of 22.00%. This contributed to the annual value of -0.32% for FY2024, which is 1.00% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Return on Capital Employed is -0.19%, which was up 35.23% from -0.29% recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Return on Capital Employed ranged from a high of -0.16% in Q1 2021 and a low of -0.42% during Q2 2024.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.33% (2025), whereas its average is -0.33%.
  • As far as peak fluctuations go, Adaptive Biotechnologies' Return on Capital Employed decreased by 15bps in 2024, and later grew by 22bps in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Return on Capital Employed (Quarterly) stood at -0.25% in 2021, then decreased by 2bps to -0.26% in 2022, then dropped by 11bps to -0.38% in 2023, then grew by 2bps to -0.36% in 2024, then increased by 22bps to -0.19% in 2025.
  • Its Return on Capital Employed stands at -0.19% for Q3 2025, versus -0.29% for Q2 2025 and -0.33% for Q1 2025.